melatonin has been researched along with Dyspnea in 3 studies
Dyspnea: Difficult or labored breathing.
Excerpt | Relevance | Reference |
---|---|---|
"Dyspnea was improved by melatonin (P=0." | 2.77 | Melatonin reduces lung oxidative stress in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled study. ( Andrade, GM; Cavalcante, MM; de Bruin, PF; de Bruin, VM; de Matos Cavalcante, AG; Nunes, DM; Pereira, ED, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Wang, XC | 1 |
Wu, GL | 1 |
Cai, YF | 1 |
Zhang, SJ | 1 |
de Matos Cavalcante, AG | 1 |
de Bruin, PF | 1 |
de Bruin, VM | 1 |
Nunes, DM | 1 |
Pereira, ED | 1 |
Cavalcante, MM | 1 |
Andrade, GM | 1 |
Cagnoni, ML | 1 |
Lombardi, A | 1 |
Cerinic, MC | 1 |
Dedola, GL | 1 |
Pignone, A | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Effects of Oral Melatonin on Neurosensory Recovery Following Facial Osteotomies - A Randomised, Controlled Clinical Trial[NCT02889432] | Phase 2 | 40 participants (Anticipated) | Interventional | 2016-06-30 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for melatonin and Dyspnea
Article | Year |
---|---|
The safety and efficacy of melatonin in the treatment of COVID-19: A systematic review and meta-analysis.
Topics: C-Reactive Protein; Cough; COVID-19 Drug Treatment; Dyspnea; Humans; Melatonin; SARS-CoV-2 | 2022 |
1 trial available for melatonin and Dyspnea
Article | Year |
---|---|
Melatonin reduces lung oxidative stress in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled study.
Topics: Aged; Aged, 80 and over; Antioxidants; Dinoprost; Double-Blind Method; Dyspnea; Female; Humans; Lung | 2012 |
1 other study available for melatonin and Dyspnea
Article | Year |
---|---|
Melatonin for treatment of chronic refractory sarcoidosis.
Topics: Adult; Chronic Disease; Dyspnea; Female; Humans; Lung Diseases; Melatonin; Middle Aged; Sarcoidosis; | 1995 |